| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |